CATALENT, INC. (CTLT)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$0.44 (+0.72%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of CATALENT, INC. (CTLT)
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.

Key Insights

Critical company metrics and information
  • Share Price

    $61.85
  • Market Cap

    $11.23 Billion
  • Total Outstanding Shares

    181.51 Million Shares
  • Total Employees

    16,900
  • Dividend

    No dividend
  • IPO Date

    July 31, 2014
  • SIC Description

    Pharmaceutical Preparations
  • Homepage

    https://www.catalent.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Operating Activities$399.00 Million
Net Cash Flow, Continuing$88.00 Million
Net Cash Flow From Investing Activities, Continuing$-277.00 Million
Net Cash Flow$126.00 Million
Net Cash Flow From Financing Activities$-34.00 Million
Exchange Gains/Losses$38.00 Million
Net Cash Flow From Investing Activities$-277.00 Million
Net Cash Flow From Operating Activities, Continuing$399.00 Million
Net Cash Flow From Financing Activities, Continuing$-34.00 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Operating Expenses$1.05 Billion
Provision For Loan, Lease, And Other Losses$0.00
Net Income/Loss Attributable To Parent$-413.00 Million
Depreciation and Amortization$490.00 Million
Basic Average Shares$546.00 Million
Benefits Costs and Expenses$4.77 Billion
Diluted Average Shares$546.00 Million
Interest Income/Expense Operating, Net$-256.00 Million
Income/Loss From Continuing Operations After Tax$-413.00 Million
Revenues$4.42 Billion
Operating Income/Loss$-90.00 Million
Net Income/Loss$-413.00 Million
Income/Loss From Continuing Operations Before Tax$-347.00 Million
Interest Income/Expense After Provision For Losses$-256.00 Million
Basic Earnings Per Share$2.29
Preferred Stock Dividends And Other Adjustments$0.00
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Gross Profit$965.00 Million
Nonoperating Income/Loss$47.00 Million
Net Income/Loss Available To Common Stockholders, Basic$-413.00 Million
Selling, General, and Administrative Expenses$982.00 Million
Cost Of Revenue$3.46 Billion
Research and Development$17.00 Million
Diluted Earnings Per Share$2.29
Costs And Expenses$4.77 Billion
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Income Tax Expense/Benefit$66.00 Million

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Equity Attributable To Parent$3.54 Billion
Other Non-current Assets$2.72 Billion
Wages$127.00 Million
Liabilities$6.17 Billion
Equity$3.54 Billion
Equity Attributable To Noncontrolling Interest$0.00
Noncurrent Liabilities$5.17 Billion
Noncurrent Assets$7.20 Billion
Fixed Assets$3.67 Billion
Prepaid Expenses$59.00 Million
Other Current Liabilities$496.00 Million
Other Current Assets$1.90 Billion
Intangible Assets$811.00 Million
Assets$9.71 Billion
Liabilities And Equity$9.71 Billion
Current Assets$2.51 Billion
Accounts Payable$375.00 Million
Current Liabilities$998.00 Million
Inventory$553.00 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.